These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19097893)

  • 21. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
    Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor.
    Pérez-Benito L; Doornbos MLJ; Cordomí A; Peeters L; Lavreysen H; Pardo L; Tresadern G
    Structure; 2017 Jul; 25(7):1153-1162.e4. PubMed ID: 28648611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease.
    Le Poul E; Boléa C; Girard F; Poli S; Charvin D; Campo B; Bortoli J; Bessif A; Luo B; Koser AJ; Hodge LM; Smith KM; DiLella AG; Liverton N; Hess F; Browne SE; Reynolds IJ
    J Pharmacol Exp Ther; 2012 Oct; 343(1):167-77. PubMed ID: 22787118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
    Layton ME; Reif AJ; Hartingh TJ; Rodzinak K; Dudkin V; Wang C; Arrington K; Kelly MJ; Garbaccio RM; O'Brien JA; Magliaro BC; Uslaner JM; Huszar SL; Fillgrove KL; Tang C; Kuo Y; Jacobson MA
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1260-4. PubMed ID: 26810316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5.
    Zysk JR; Spear N; Fieles W; Stein MM; Sygowski LS; King MM; Hoesch V; Hastings R; Brockel B; Do M; Ström P; Gadient R; Chhajlani V; Elmore CS; Maier DL
    Synapse; 2013 Mar; 67(3):135-44. PubMed ID: 23150216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lead optimization of the VU0486321 series of mGlu
    Davis DC; Bungard JD; Chang S; Rodriguez AL; Blobaum AL; Boutaud O; Melancon BJ; Niswender CM; Jeffrey Conn P; Lindsley CW
    Bioorg Med Chem Lett; 2021 Jan; 32():127724. PubMed ID: 33253881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy.
    Gogliotti RD; Engers DW; Garcia-Barrantes PM; Panarese JD; Gentry PR; Blobaum AL; Morrison RD; Daniels JS; Thompson AD; Jones CK; Conn PJ; Niswender CM; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2915-2919. PubMed ID: 27131990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and optimization of a novel CNS penetrant series of mGlu
    Kent CN; Fulton MG; Stillwell KJ; Dickerson JW; Loch MT; Rodriguez AL; Blobaum AL; Boutaud O; Rook JL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2021 Apr; 37():127838. PubMed ID: 33556572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent progress in the development of allosteric modulators of mGluR5.
    Rodriguez AL; Williams R
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):715-22. PubMed ID: 17987523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive allosteric modulators (PAMs) of the group II metabotropic glutamate receptors: Design, synthesis, and evaluation as ex-vivo tool compounds.
    Yamada Y; Gilliland K; Xiang Z; Haymer D; Crocker KE; Loch MT; Schulte ML; Rodriguez AL; Niswender CM; Jeffrey Conn P; Lindsley CW; Melancon BJ
    Bioorg Med Chem Lett; 2021 Oct; 50():128342. PubMed ID: 34461178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats.
    Engers DW; Field JR; Le U; Zhou Y; Bolinger JD; Zamorano R; Blobaum AL; Jones CK; Jadhav S; Weaver CD; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    J Med Chem; 2011 Feb; 54(4):1106-10. PubMed ID: 21247167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators.
    Jimenez HN; Liu KG; Hong SP; Reitman MS; Uberti MA; Bacolod MD; Cajina M; Nattini M; Sabio M; Doller D
    Bioorg Med Chem Lett; 2012 May; 22(9):3235-9. PubMed ID: 22465637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computationally Guided Identification of Allosteric Agonists of the Metabotropic Glutamate 7 Receptor.
    Cid JM; Lavreysen H; Tresadern G; Pérez-Benito L; Tovar F; Fontana A; Trabanco AA
    ACS Chem Neurosci; 2019 Mar; 10(3):1043-1054. PubMed ID: 30216043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the active conformation of cyclohexane carboxylate positive allosteric modulators of the type 4 metabotropic glutamate receptor.
    Rovira X; Harrak Y; Trapero A; González-Bulnes P; Malhaire F; Pin JP; Goudet C; Giraldo J; Llebaria A
    ChemMedChem; 2014 Dec; 9(12):2685-98. PubMed ID: 25196639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS).
    Engers DW; Gentry PR; Williams R; Bolinger JD; Weaver CD; Menon UN; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5175-8. PubMed ID: 20667732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy switching SAR of mGluR5 allosteric modulators: highly potent positive and negative modulators from one chemotype.
    Sams AG; Mikkelsen GK; Brodbeck RM; Pu X; Ritzén A
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3407-10. PubMed ID: 21531137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
    O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
    Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and SAR of a novel series of non-MPEP site mGlu₅ PAMs based on an aryl glycine sulfonamide scaffold.
    Rodriguez AL; Zhou Y; Williams R; Weaver CD; Vinson PN; Dawson ES; Steckler T; Lavreysen H; Mackie C; Bartolomé JM; Macdonald GJ; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7388-92. PubMed ID: 23142615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs).
    Szabó G; Kolok S; Orgován Z; Vastag M; Béni Z; Kóti J; Sághy K; Lévay GI; Greiner I; Keserű GM
    Eur J Med Chem; 2020 Jan; 186():111881. PubMed ID: 31780081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2.
    Farinha A; Lavreysen H; Peeters L; Russo B; Masure S; Trabanco AA; Cid J; Tresadern G
    Br J Pharmacol; 2015 May; 172(9):2383-96. PubMed ID: 25571949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.